In the last trading session, 1.7 million Altimmune Inc (NASDAQ:ALT) shares changed hands as the company’s beta touched 0.03. With the company’s per share price at $9.08 changed hands at -$0.03 or -0.33% during last session, the market valuation stood at $487.87M. ALT’s last price was a discount, traded about -63.44% off its 52-week high of $14.84. The share price had its 52-week low at $2.09, which suggests the last value was 76.98% up since then. When we look at Altimmune Inc’s average trading volume, we note the 10-day average is 4.38 million shares, with the 3-month average coming to 6.78 million.
Altimmune Inc (NASDAQ:ALT) trade information
Instantly ALT was in red as seen at the end of in last trading. With action -7.91%, the performance over the past five days has been red. The drop to weekly highs of 9.77 subtracted -0.33% to the stock’s daily price. The company’s shares are showing year-to-date downside of -19.29%, with the 5-day performance at -7.91% in the red. However, in the 30-day time frame, Altimmune Inc (NASDAQ:ALT) is 2.37% up. Looking at the short shares, we see there were 10.81 million shares sold at short interest cover period of 1.81 days.
Altimmune Inc (ALT) estimates and forecasts
Data shows that the Altimmune Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 254.69% over the past 6 months, a 20.99% in annual growth rate that is considerably higher than the industry average of 10.40%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 56.82%. The 2024 estimates are for Altimmune Inc earnings to increase by 18.02%.
ALT Dividends
Altimmune Inc is expected to release its next quarterly earnings report on March 27.
Altimmune Inc (NASDAQ:ALT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.02% of Altimmune Inc shares while 68.26% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 68.96%. There are 68.26% institutions holding the Altimmune Inc stock share, with Blackrock Inc. the top institutional holder. As of Jun 29, 2023, the company held 6.95% of the shares, roughly 3.66 million ALT shares worth $12.93 million.
Nuveen Asset Management, LLC holds the second largest percentage of outstanding shares, with 6.57% or 3.46 million shares worth $12.21 million as of Jun 29, 2023.
Among Mutual Funds, the top two as of Jun 29, 2023 were College Retirement Equities Fund-Stock Account and Vanguard Total Stock Market Index Fund. With 2.0 million shares estimated at $7.05 million under it, the former controlled 3.79% of total outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held about 3.07% of the shares, roughly 1.62 million shares worth around $5.71 million.
